It´s a clinical research of the effects in portal hypertension caused by simvastatin. We are
going to use the hepatic venous pressure gradient(HVPG) measurement and the azygos flow at
echoendoscopy to evaluate the benefits of the drug. Preliminary studies demonstrated that
simvastatin can lower portal pressure.
Phase:
Phase 3
Details
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Collaborator:
Rio de Janeiro State Research Supporting Foundation (FAPERJ)